Michael Becker to Tumor Necrosis Factor-alpha
This is a "connection" page, showing publications Michael Becker has written about Tumor Necrosis Factor-alpha.
Connection Strength
0.012
-
Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease. Biol Blood Marrow Transplant. 2005 Sep; 11(9):680-7.
Score: 0.012
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.